Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Expands Russian OTC Foothold Via J.B. Chemicals Portfolio Acquisition

This article was originally published in PharmAsia News

Executive Summary

Johnson & Johnson expands its consumer health presence in Russia and other Eastern European markets with the acquisition of several OTC brands from J.B. Chemicals & Pharmaceuticals
Advertisement

Related Content

Emerging Views On Emerging Markets: Credit Suisse Healthcare Conference
J&J And India’s J.B. Chemicals On Collision Course As Sale Of Russian OTC Business Hits Snag
J&J And India’s J.B. Chemicals On Collision Course As Sale Of Russian OTC Business Hits Snag
Emerging Views On Emerging Markets: Cowen Group Healthcare Conference
Emerging Views On Emerging Markets: Cowen Group Healthcare Conference
Back To Square One: India's J.B.Chemicals, Dr. Reddy's Terminate Russa Rx Deal
Aurobindo Accesses Russian OTC Market Through Deal With Diod
Dr. Reddy's Labs Saved From Poor India Showing By North America Market Growth, Biosimilars
Pfizer Buys Ferrosan Consumer Unit, Expands In Russia And Northern Europe
Pfizer Buys Ferrosan Consumer Unit, Expands In Russia And Northern Europe
Advertisement
UsernamePublicRestriction

Register

SC078088

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel